Labcorp Holdings (LH) Receivables - Other (2012 - 2026)

Labcorp Holdings has disclosed Receivables - Other across 13 years of filings, most recently posting $161.9 million for Q1 2026.

• Receivables - Other for Q1 2026 came in at $161.9 million, up 7.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $161.9 million (up 7.01% YoY), and the FY2025 annual result was $156.9 million, up 2.62% from the prior year.
• Receivables - Other came in at $161.9 million for Q1 2026 at Labcorp Holdings, up from $156.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $827.4 million in Q2 2022 to a low of $108.0 million in Q3 2023.
• The 5-year median for Receivables - Other is $157.5 million (2024), against an average of $304.3 million.
• Across the five-year window, Receivables - Other tumbled 86.81% in 2023 and surged 53.98% in 2024, its largest moves.
• Labcorp Holdings' Receivables - Other stood at $211.8 million in 2022, then dropped by 12.46% to $185.4 million in 2023, then retreated by 17.53% to $152.9 million in 2024, then advanced by 2.62% to $156.9 million in 2025, then climbed by 3.19% to $161.9 million in 2026.
• The last three Receivables - Other figures came in at $161.9 million (Q1 2026), $156.9 million (Q4 2025), and $156.1 million (Q3 2025), per Business Quant data.